OTC - PURPOSE SECTION
Uses：
For Brightening Skin Tone
Extreme Shine BodyLotion
- Manufacturer
- Guangzhou Kadiya Biotechnology Co., Ltd.
- Effective date
- 2024-07-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:16:53
Label at a glance#
ProductExtreme Shine BodyLotion
Active ingredientNIACINAMIDE, APPLE, KOJIC DIPALMITATE
Label structure8 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
AQUA、MINERAL OIL、GLYCERIN、CETEARYL ALCOHOL、UREA、GLYCERYL STEARATE、PEG-100 STEARATE、CETEARETH-20、POTASSIUM CETYL PHOSPHATE、C13-16 ISOPARAFFIN、DIMETHICONE、DMDM HYDANTOIN、BUTYLENE GLYCOL、IODOPROPYNYL BUTYLCARBAMATE、METHYLPARABEN、CARBOMER、ALLANTOIN、TRIETHANOLAMINE、AROMA、SODIUM METABISULFITE、PROPYLPARABEN、DISODIUM EDTA、3-o-ETHYL ASCORBIC ACID
WARNINGS SECTION
Warning.
1.Before use, perform a skin test on your arm and discontinue use if you have allergy symptoms or skin abnormalities.
2、For external use only, avoid contact with eyes when used
3、Keep out of reach of children
INDICATIONS & USAGE SECTION
On provioushy cloansod skin. annly vour ovtrome shine bodmilk morning and evening, visible result after 7 days of use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN SECTION
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
PYRUS MALUS FRUIT EXTRACT 0.5%
KOJIC DIPALMITATE 0.39%
NIACINAMIDE 1.04%
DOSAGE & ADMINISTRATION SECTION
On provioushy cloansod skin. annly vour ovtrome shine bodmilk morning and evening, visible result after 7 days of use.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Drug Facts
Active Ingredients
PYRUS MALUS FRUIT EXTRACT 0.5%
KOJIC DIPALMITATE 0.39%
NIACINAMIDE 1.04%
Uses：
For Brightening Skin Tone
The storage method：
Store sealed in a cool place and out of sunlight
Warning.
1.Before use, perform a skin test on your arm and discontinue use if you have allergy symptoms or skin abnormalities.
2、For external use only, avoid contact with eyes when used
3、Keep out of reach of children
Inactive ingredients：
AQUA、MINERAL OIL、GLYCERIN、CETEARYL ALCOHOL、UREA、GLYCERYL STEARATE、PEG-100 STEARATE、CETEARETH-20、POTASSIUM CETYL PHOSPHATE、C13-16 ISOPARAFFIN、DIMETHICONE、DMDM HYDANTOIN、BUTYLENE GLYCOL、IODOPROPYNYL BUTYLCARBAMATE、METHYLPARABEN、CARBOMER、ALLANTOIN、TRIETHANOLAMINE、AROMA、SODIUM METABISULFITE、PROPYLPARABEN、DISODIUM EDTA、3-o-ETHYL ASCORBIC ACID
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| APPLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84423-026-01 | Extreme Shine BodyLotion | 500 mL in 1 BOTTLE, PUMP | EMULSION | 500 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Extreme Shine BodyLotion
- EDETATE DISODIUM
- DMDM HYDANTOIN
- C13-16 ISOPARAFFIN
- NIACINAMIDE
- MINERAL OIL
- APPLE
- TROLAMINE
- CETOSTEARYL ALCOHOL
- CARBOXYPOLYMETHYLENE
- ALLANTOIN
- UREA
- PEG-100 STEARATE
- DIMETHICONE
- KOJIC DIPALMITATE
- WATER
- POTASSIUM CETYL PHOSPHATE
- SODIUM METABISULFITE
- PROPYLPARABEN
- 3-O-ETHYL ASCORBIC ACID
- GLYCERIN
- GLYCERYL MONOSTEARATE
- POLYOXYL 20 CETOSTEARYL ETHER
- BUTYLENE GLYCOL
- IODOPROPYNYL BUTYLCARBAMATE
- METHYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84423-026 | 84423-026-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1df5311e-7e4e-91ca-e063-6294a90adda1 | 1df5311e-7e4d-91ca-e063-6294a90adda1 | 2024-07-23 | Warnings | 1df5311e-7e4e-91ca-e063-6294a90adda1 1df5311e-7e4d-91ca-e063-6294a90adda1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.